BiomX Reports Second Quarter 2025 Financial Results and Provides Program Updates

BiomX Inc Positive Phase 2 results for BX211 demonstrated >40% wound size reduction vs. placebo in diabetic foot…
#NewsBeep #News #Headlines #BiomX #BiomXInc. #clinicalsignificance #diabeticfootinfections #financialresults #Latvia #LV #NatureCommunications #phagetherapies #toplineresults
https://www.newsbeep.com/57776/